There will be no impact to sales until end of this year. The FDA approval for GLP drugs will come start of next year. The issue is not of the numbers Resmed will report for the next few quarters. It's more about what will happen mid next year onwards.
There will be no impact to sales until end of this year. The FDA...
-
- There are more pages in this discussion • 57 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RMD (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$33.71 |
Change
0.390(1.17%) |
Mkt cap ! $21.66B | |||
| Open | High | Low | Value | Volume |
| $33.41 | $33.71 | $33.41 | $54.92M | 1.633M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 140 | $33.65 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $33.72 | 36 | 1 |
View Market Depth
| Last trade - 16.10pm 15/08/2024 (20 minute delay) ? |
| RMD (ASX) Chart |